Clinical Trial Update: Study of SAR421869 in Participants With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of SAR421869 in participants with retinitis pigmentosa associated with Usher syndrome type 1B was terminated; results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa
• Usher Syndrome

Drugs mentioned

• SAR421869

Snippet

Sponsor: Sanofi | Conditions: Usher Syndrome, Retinitis Pigmentosa | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-03-18